Allogeneic Expanded Gamma Delta T Cells With GD2 Chemoimmunotherapy in Relapsed /Refractory Neuroblastoma or Refractory/ Relapsed Osteosarcoma

Clinical trial NCT05400603 · RECRUITING

Trial details

NCT number: NCT05400603
Sponsor: Emory University
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Neuroblastoma Refractory Neuroblastoma Relapsed Neuroblastoma Relapsed Osteosarcoma Refractory Osteosarcoma

Start date: 2023-11-06
Primary completion: 2026-12-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.